Zymeworks
ZYME
123 hedge funds and large institutions have $1.07B invested in Zymeworks in 2021 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 40 increasing their positions, 29 reducing their positions, and 15 closing their positions.
100% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 15
70% more call options, than puts
Call options by funds: $6.28M | Put options by funds: $3.7M
38% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 29
13% more funds holding
Funds holding: 109 → 123 (+14)
4.64% more ownership
Funds ownership: 74.79% → 79.43% (+4.6%)
11% less capital invested
Capital invested by funds: $1.2B → $1.07B (-$131M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$24.9M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$21.5M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$19.9M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$17.6M |
| 5 |
AC
Armistice Capital
New York
|
+$17.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Holocene Advisors
New York
|
-$32M |
| 2 |
PA
Perceptive Advisors
New York
|
-$20.8M |
| 3 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$16.4M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$12.4M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$6.64M |
ZYME Hedge Fund Activity: Q3 2021 in Review
123 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q3 2021, worth a combined $1.07B — down 11% from $1.2B a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new ZYME positions and 15 closed out — a net gain of 15 holders — while 40 added to existing stakes and 29 trimmed.
The largest buyer was Camber Capital Management, opening a new position worth an estimated $24.9M. The largest seller was Holocene Advisors, exiting entirely with an estimated $32M sold.
- 123 institutional investors held Zymeworks (ZYME) as of Q3 2021, up from 109 in Q2 2021.
- Funds reported $1.07B of Zymeworks stock for Q3 2021, down 11% quarter-over-quarter.
- 30 funds opened new Zymeworks positions in Q3 2021 and 15 closed out, a net change of +15 holders.
- The largest Zymeworks buyer in Q3 2021 was Camber Capital Management, an estimated $24.9M added.
- The largest Zymeworks seller in Q3 2021 was Holocene Advisors, an estimated $32M sold.
Based on aggregated 13F filings for Q3 2021.